Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Operating Leases (2022 - 2026)

NeuroPace has reported Operating Leases over the past 5 years, most recently at $11.4 million for Q1 2026.

  • For Q1 2026, Operating Leases fell 14.39% year-over-year to $11.4 million; the TTM value through Mar 2026 reached $11.4 million, down 14.39%, while the annual FY2025 figure was $9.8 million, 17.71% down from the prior year.
  • Operating Leases for Q1 2026 was $11.4 million at NeuroPace, up from $9.8 million in the prior quarter.
  • Over five years, Operating Leases peaked at $16.4 million in Q3 2022 and troughed at $3.2 million in Q2 2022.
  • A 5-year average of $12.6 million and a median of $12.9 million in 2024 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: surged 354.36% in 2023 and later decreased 21.34% in 2024.
  • Year by year, Operating Leases stood at $15.4 million in 2022, then decreased by 10.53% to $13.8 million in 2023, then dropped by 13.47% to $12.0 million in 2024, then fell by 17.71% to $9.8 million in 2025, then grew by 16.32% to $11.4 million in 2026.
  • Business Quant data shows Operating Leases for NPCE at $11.4 million in Q1 2026, $9.8 million in Q4 2025, and $12.4 million in Q3 2025.